Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1908-1912

  Okada, Hiroshi ^a   Fukui, Michiaki ^a   Tanaka, Muhei ^a   Matsumoto, Shinobu ^a   Mineoka, Yusuke ^a   Nakanishi, Naoko ^a   Asano, Mai ^a   Yamazaki, Masahiro ^a   Hasegawa, Goji ^a   Nakamura, Naoto ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE VARIABILITY; COHORT ANALYSIS; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINARY ALBUMIN EXCRETION; URINARY EXCRETION;

AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84885962029     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2087     Document Type: Article

References (20)

1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689
2. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982;248:1465-1477
3. Drury PL, Ting R, Zannino D, et al. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2011; 54:32-43
4. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157: 1413-1418
5. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011;57:160-166
6. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905
7. Hata Y, Kimura Y,Muratani H, et al.Office blood pressure variability as a predictor of brain infarction in elderly hypertensive patients. Hypertens Res 2000;23:553-560
8. Hata Y, Muratani H, Kimura Y, et al.Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy. J Hum Hypertens 2002;16:141-146
9. Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes.DiabetesCare 2010;33:2442-2447
10. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012;126:569-578
11. Okada H, Fukui M, Tanaka M, et al. Visitto-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012;220:155-159
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26(Suppl. 1): S5-S20
13. Wu AY, Low LP. Managing vascular risk in hypertension with a focus on microalbuminuria:attitude and practices. Singapore Med J 2009;50:976-981
14. Modesti PA, Morabito M, Bertolozzi I, et al. Weather-related changes in 24- hour blood pressure profile: effects of age and implications for hypertension management. Hypertension 2006;47:155-161
15. Parati G, Ochoa JE, Bilo G. Blood pressure variability, cardiovascular risk, and risk for renal disease progression. Curr Hypertens Rep 2012;14:421-431
16. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens 2012;30:1241-1251
17. Kawai T, Ohishi M, Kamide K, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res 2012;35:239-243
18. Eto M, Toba K, Akishita M, et al. Reduced endothelial vasomotor function and enhanced neointimal formation after vascular injury in a rat model of blood pressure lability. Hypertens Res 2003;26:991-998
19. Diaz KM, Veerabhadrappa P, KashemMA, et al. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res 2012;35:55-61
20. Ruggenenti P, Porrini E, Motterlini N, et al.; BENEDICT Study Investigators. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes. J Am Soc Nephrol 2012;23:1717-1724